Bladder cancer other imaging findings

Jump to navigation Jump to search

Bladder cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bladder cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Electrocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bladder cancer other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bladder cancer other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bladder cancer other imaging findings

CDC on Bladder cancer other imaging findings

Bladder cancer other imaging findings in the news

Blogs on Bladder cancer other imaging findings

Directions to Hospitals Treating Bladder cancer

Risk calculators and risk factors for Bladder cancer other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

Cystoscopy may be helpful for initial diagnosis and staging of bladder cancer. Findings of cystoscopy include Multiple bladder biopsy specimens from various locations and gross extravesical extension, invasion of adjacent organs, or pelvic sidewall involvement.

Other Imaging Findings

  • Cystoscopy may be helpful in the diagnosis of bladder cancer. Findings diagnostic of bladder cancer include:[1][2][3]
    • Multiple bladder biopsy specimens from various locations
    • Gross extravesical extension, invasion of adjacent organs, or pelvic sidewall involvement
    • Detects more tumors (both papillary and CIS) with fluorescence cystoscopy than white-light cystoscopy


References

  1. Shariat SF, Karam JA, Lotan Y, Karakiewizc PI (2008). "Critical evaluation of urinary markers for bladder cancer detection and monitoring". Rev Urol. 10 (2): 120–35. PMC 2483317. PMID 18660854.
  2. Krieg RC, Messmann H, Rauch J, Seeger S, Knuechel R (November 2002). "Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells". Photochem. Photobiol. 76 (5): 518–25. PMID 12462647.
  3. Wiener HG, Mian C, Haitel A, Pycha A, Schatzl G, Marberger M (June 1998). "Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?". J. Urol. 159 (6): 1876–80. PMID 9598479.

Template:WH Template:WS